Recurrent Pericarditis Market is driven by Emerging Therapeutics
The Recurrent Pericarditis Market encompasses a range of pharmaceutical products and interventions designed to manage inflammation of the pericardium that recurs after initial treatment. Key therapies include non-steroidal anti-inflammatory drugs (NSAIDs), colchicine, corticosteroids, and advanced biologics such as interleukin-1 inhibitors. These treatments offer distinct advantages: NSAIDs...
0 Comments 0 Shares 147 Views 0 Reviews